Cargando…
P1172: DUVELISIB IN PATIENTS WITH RELAPSED/REFRACTORY PERIPHERAL T-CELL LYMPHOMA FROM THE PHASE 2 PRIMO TRIAL: UPDATED EXPANSION PHASE ANALYSIS
| Autores principales: | , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430404/ http://dx.doi.org/10.1097/01.HS9.0000847552.42271.7c |
| _version_ | 1784779759986671616 |
|---|---|
| author | Zinzani, P. L. Zain, J. Mead, M. Casulo, C. Jacobsen, E. D. Gritti, G. Pinter-Brown, L. Isutzu, K. Cohan, D. Daugherty, M. Brammer, J. E. Mehta-Shah, N. Pro, B. Horwitz, S. M. |
| author_facet | Zinzani, P. L. Zain, J. Mead, M. Casulo, C. Jacobsen, E. D. Gritti, G. Pinter-Brown, L. Isutzu, K. Cohan, D. Daugherty, M. Brammer, J. E. Mehta-Shah, N. Pro, B. Horwitz, S. M. |
| author_sort | Zinzani, P. L. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9430404 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94304042022-08-31 P1172: DUVELISIB IN PATIENTS WITH RELAPSED/REFRACTORY PERIPHERAL T-CELL LYMPHOMA FROM THE PHASE 2 PRIMO TRIAL: UPDATED EXPANSION PHASE ANALYSIS Zinzani, P. L. Zain, J. Mead, M. Casulo, C. Jacobsen, E. D. Gritti, G. Pinter-Brown, L. Isutzu, K. Cohan, D. Daugherty, M. Brammer, J. E. Mehta-Shah, N. Pro, B. Horwitz, S. M. Hemasphere Posters Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9430404/ http://dx.doi.org/10.1097/01.HS9.0000847552.42271.7c Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Zinzani, P. L. Zain, J. Mead, M. Casulo, C. Jacobsen, E. D. Gritti, G. Pinter-Brown, L. Isutzu, K. Cohan, D. Daugherty, M. Brammer, J. E. Mehta-Shah, N. Pro, B. Horwitz, S. M. P1172: DUVELISIB IN PATIENTS WITH RELAPSED/REFRACTORY PERIPHERAL T-CELL LYMPHOMA FROM THE PHASE 2 PRIMO TRIAL: UPDATED EXPANSION PHASE ANALYSIS |
| title | P1172: DUVELISIB IN PATIENTS WITH RELAPSED/REFRACTORY PERIPHERAL T-CELL LYMPHOMA FROM THE PHASE 2 PRIMO TRIAL: UPDATED EXPANSION PHASE ANALYSIS |
| title_full | P1172: DUVELISIB IN PATIENTS WITH RELAPSED/REFRACTORY PERIPHERAL T-CELL LYMPHOMA FROM THE PHASE 2 PRIMO TRIAL: UPDATED EXPANSION PHASE ANALYSIS |
| title_fullStr | P1172: DUVELISIB IN PATIENTS WITH RELAPSED/REFRACTORY PERIPHERAL T-CELL LYMPHOMA FROM THE PHASE 2 PRIMO TRIAL: UPDATED EXPANSION PHASE ANALYSIS |
| title_full_unstemmed | P1172: DUVELISIB IN PATIENTS WITH RELAPSED/REFRACTORY PERIPHERAL T-CELL LYMPHOMA FROM THE PHASE 2 PRIMO TRIAL: UPDATED EXPANSION PHASE ANALYSIS |
| title_short | P1172: DUVELISIB IN PATIENTS WITH RELAPSED/REFRACTORY PERIPHERAL T-CELL LYMPHOMA FROM THE PHASE 2 PRIMO TRIAL: UPDATED EXPANSION PHASE ANALYSIS |
| title_sort | p1172: duvelisib in patients with relapsed/refractory peripheral t-cell lymphoma from the phase 2 primo trial: updated expansion phase analysis |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430404/ http://dx.doi.org/10.1097/01.HS9.0000847552.42271.7c |
| work_keys_str_mv | AT zinzanipl p1172duvelisibinpatientswithrelapsedrefractoryperipheraltcelllymphomafromthephase2primotrialupdatedexpansionphaseanalysis AT zainj p1172duvelisibinpatientswithrelapsedrefractoryperipheraltcelllymphomafromthephase2primotrialupdatedexpansionphaseanalysis AT meadm p1172duvelisibinpatientswithrelapsedrefractoryperipheraltcelllymphomafromthephase2primotrialupdatedexpansionphaseanalysis AT casuloc p1172duvelisibinpatientswithrelapsedrefractoryperipheraltcelllymphomafromthephase2primotrialupdatedexpansionphaseanalysis AT jacobsened p1172duvelisibinpatientswithrelapsedrefractoryperipheraltcelllymphomafromthephase2primotrialupdatedexpansionphaseanalysis AT grittig p1172duvelisibinpatientswithrelapsedrefractoryperipheraltcelllymphomafromthephase2primotrialupdatedexpansionphaseanalysis AT pinterbrownl p1172duvelisibinpatientswithrelapsedrefractoryperipheraltcelllymphomafromthephase2primotrialupdatedexpansionphaseanalysis AT isutzuk p1172duvelisibinpatientswithrelapsedrefractoryperipheraltcelllymphomafromthephase2primotrialupdatedexpansionphaseanalysis AT cohand p1172duvelisibinpatientswithrelapsedrefractoryperipheraltcelllymphomafromthephase2primotrialupdatedexpansionphaseanalysis AT daughertym p1172duvelisibinpatientswithrelapsedrefractoryperipheraltcelllymphomafromthephase2primotrialupdatedexpansionphaseanalysis AT brammerje p1172duvelisibinpatientswithrelapsedrefractoryperipheraltcelllymphomafromthephase2primotrialupdatedexpansionphaseanalysis AT mehtashahn p1172duvelisibinpatientswithrelapsedrefractoryperipheraltcelllymphomafromthephase2primotrialupdatedexpansionphaseanalysis AT prob p1172duvelisibinpatientswithrelapsedrefractoryperipheraltcelllymphomafromthephase2primotrialupdatedexpansionphaseanalysis AT horwitzsm p1172duvelisibinpatientswithrelapsedrefractoryperipheraltcelllymphomafromthephase2primotrialupdatedexpansionphaseanalysis |